Mon.May 23, 2022

article thumbnail

Concert drug helps regrow hair in study, boosting shares

Bio Pharma Dive

There are no treatments specifically approved for alopecia areata. Concert follows Pfizer and Eli Lilly in reporting positive late-stage results for drugs they're developing for the autoimmune disorder.

Drugs 283
article thumbnail

PTC Therapeutic’s Upstaza has been recommended by both the EMA and CHMP

Pharma Times

It is the first gene therapy to be directly administered into the brain to treat aromatic L-amino acid decarboxylase (AADC) deficiency

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Common barriers to patient engagement: What's your strategy?

Bio Pharma Dive

As with treatment, and even adherence, there is no 'one size fits all' when it comes to patient engagement.

246
246
article thumbnail

Kidfresh: The Better-For-You Kid’s Brand with Hidden Veggies

XTalks

Kidfresh, a New York-based brand of frozen children’s food featuring hidden veggies, recently added two new products to its robust lineup of frozen meals. The new Cheeseburger Mac & Cheese and Cheese Pizza Wagon Wheels feature high-quality ingredients and hidden carrots and beets. Both entrees contain 13 grams of protein, are good sources of calcium and are free from preservatives and artificial ingredients.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Biohaven hits setback as it moves beyond migraine

Bio Pharma Dive

The company's experimental treatment for spinocerebellar ataxia is one of several drugs meant to form the pipeline of the "New Biohaven" that will be spun out after Pfizer's planned acquisition.

Drugs 158
article thumbnail

Takeda, Daiichi-backed wearable study planned in Japan

pharmaphorum

A study that will look at the feasibility of tracking people’s lifestyle habits for an extended period using a wearable device has got underway in Japan, backed by drugmakers Takeda and Daiichi Sankyo. The device will be worn by 2,000 people for a year, harvesting data on sleep status, heart rate, and activity levels, according to the study partners, which also include digital health and telemedicine firm MICIN and Tohoku University.

More Trending

article thumbnail

Price and convenience can drive consumers to purchase cannabis from illegal, rather than legal, sources: Study

Scienmag

PISCATAWAY, NJ—Despite the legalization of cannabis sales in Canada and many U.S. states, an illegal market still exists. A new study in the Journal of Studies on Alcohol and Drugs suggests that higher prices and inconvenience associated with legal sources may be barriers that encourage consumers to seek out illegal providers instead. Credit: Katherine Hitt […].

Sales 89
article thumbnail

How do you expand cell therapy manufacturing to reach more patients per year?

BioPharma Reporter

The potential of cell therapy is proven, but its impact is limited by manufacturing bottlenecks.

article thumbnail

Low-cost gel film can pluck drinking water from desert air

Scienmag

More than a third of the world’s population lives in drylands, areas that experience significant water shortages. Scientists and engineers at The University of Texas at Austin have developed a solution that could help people in these areas access clean drinking water. Credit: The University of Texas at Austin / Cockrell School of Engineering More than […].

article thumbnail

USAID on expanding digital health globally – part two

pharmaphorum

This article follows part one of our two-part series, in which we discussed how USAID invests in digital infrastructure as part of its development and humanitarian assistance programmes. . Adele Waugaman, senior digital health coordinator of the COVID-19 response at the United States Agency for International Development (USAID), discusses the value of establishing donor partnerships and how those collaborations can improve digital health options globally. .

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Easy as an inkjet, a new soft printing technique has opened the way for pixelated elastics

Scienmag

Borrowing a technique from inkjet printers, researchers at Princeton Engineering have rolled out a pixel-by-pixel method to program and manufacture soft structures for use in robotics, biomedical devices or architectural features. Credit: Ella Maru Studio Borrowing a technique from inkjet printers, researchers at Princeton Engineering have rolled out a pixel-by-pixel method to program and manufacture […].

article thumbnail

CHMP recommends Sanofi’s Xenpozyme for rare disease ASMD

Pharma Times

Positive opinion is based on data from clinical trials which showed improvement in lung function

article thumbnail

DeepSqueak tool identifies marine mammal calls #ASA182

Scienmag

DENVER, May 23, 2022 – Lurking beneath the ocean’s surface, marine mammals use sound for navigation, prey detection, and a wide range of natural behaviors. Passive acoustic data from underwater environments can provide valuable information on these animals, such as their presence or absence within an area, their density and abundance, and their vocal response […].

88
article thumbnail

New patent for Vero Biotech drug GENOSYL

Drug Patent Watch

Annual Drug Patent Expirations for GENOSYL Genosyl is a drug marketed by Vero Biotech and is included in one NDA. There are twenty patents protecting this drug. This drug has…. The post New patent for Vero Biotech drug GENOSYL appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Diamond mirrors for high-powered lasers

Scienmag

Just about every car, train and plane that’s been built since 1970 has been manufactured using high-power lasers that shoot a continuous beam of light. These lasers are strong enough to cut steel, precise enough to perform surgery, and powerful enough to carry messages into deep space. They are so powerful, in fact, that it’s […].

article thumbnail

New patent for Bausch drug ZYCLARA

Drug Patent Watch

Annual Drug Patent Expirations for ZYCLARA Zyclara is a drug marketed by Bausch and is included in one NDA. It is available from three suppliers. There are eight patents protecting…. The post New patent for Bausch drug ZYCLARA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Twisted soft robots navigate mazes without human or computer guidance

Scienmag

Researchers from North Carolina State University and the University of Pennsylvania have developed soft robots that are capable of navigating complex environments, such as mazes, without input from humans or computer software. Credit: Yao Zhao, NC State University Researchers from North Carolina State University and the University of Pennsylvania have developed soft robots that are […].

article thumbnail

New patent expiration for Eagle Pharms drug PEMFEXY

Drug Patent Watch

Annual Drug Patent Expirations for PEMFEXY Pemfexy is a drug marketed by Eagle Pharms and is included in one NDA. It is available from one supplier. There are two patents…. The post New patent expiration for Eagle Pharms drug PEMFEXY appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Mount Sinai launches Neural Epigenomics Research Center

Scienmag

The Icahn School of Medicine at Mount Sinai has launched a new research center devoted to understanding how epigenomics influences the nervous system under both healthy and disease conditions. The Center for Neural Epigenome Engineering aims to dramatically expand Mount Sinai’s ability to conduct research in this field, facilitating new discoveries and the development of […].

article thumbnail

New patent for Photocure Asa drug CYSVIEW KIT

Drug Patent Watch

Annual Drug Patent Expirations for CYSVIEW+KIT Cysview Kit is a drug marketed by Photocure Asa and is included in one NDA. It is available from one supplier. There are two…. The post New patent for Photocure Asa drug CYSVIEW KIT appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Girls’ chance of success at school in Sub-Saharan Africa shaped by language they are taught in

Scienmag

Millions of school children across large parts of Sub-Saharan Africa are sat silently in classrooms, struggling to follow lessons, and not progressing in their learning due to an insistence that all lessons should be taught in English, say the authors of a new report. The findings, published today as a policy brief from the University […].

84
article thumbnail

New patent expiration for LILLY drug ALIMTA

Drug Patent Watch

Annual Drug Patent Expirations for ALIMTA Alimta is a drug marketed by Lilly and is included in one NDA. It is available from one supplier. There is one patent protecting…. The post New patent expiration for LILLY drug ALIMTA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

The case for speaking politely to animals

Scienmag

The idea of horse whisperers – those with a talent for communicating with horses – may bring a chuckle to many. But according to new research from the University of Copenhagen and ETH Zurich, there may be something about their whispering skills. In an international collaboration, along with researchers Anne-Laure Maigrot and Edna Hillmann, behavioral […].

article thumbnail

New patent for NOVO drug SAXENDA

Drug Patent Watch

Annual Drug Patent Expirations for SAXENDA Saxenda is a drug marketed by Novo and is included in one NDA. It is available from two suppliers. There are twenty-three patents protecting…. The post New patent for NOVO drug SAXENDA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Foreign fishing fleets and trade are taking fish nutrients away from malnourished people

Scienmag

Foreign fishing fleets, as well as international seafood trade, are diverting vital micronutrients away from malnourished populations, a new study reveals. Credit: Nick Graham Foreign fishing fleets, as well as international seafood trade, are diverting vital micronutrients away from malnourished populations, a new study reveals. Fish are an important source of micronutrients and essential fatty […].

article thumbnail

New patent for NOVO drug OZEMPIC

Drug Patent Watch

Annual Drug Patent Expirations for OZEMPIC Ozempic is a drug marketed by Novo and is included in one NDA. It is available from three suppliers. There are twenty-three patents protecting…. The post New patent for NOVO drug OZEMPIC appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Planets of binary stars as possible homes for alien life

Scienmag

Since the only known planet with life, the Earth, orbits the Sun, planetary systems around stars of similar size are obvious targets for astronomers trying to locate extraterrestrial life. Nearly every second star in that category is a binary star. A new result from research at University of Copenhagen indicate that planetary systems are formed […].

article thumbnail

New patent for Allergan Holdings drug VIBERZI

Drug Patent Watch

Annual Drug Patent Expirations for VIBERZI Viberzi is a drug marketed by Allergan Holdings and is included in one NDA. It is available from one supplier. There are eighteen patents…. The post New patent for Allergan Holdings drug VIBERZI appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Microparticles with feeling

Scienmag

The surface of a coral is rugged. Its hard skeleton is populated by polyps that stretch their tentacles into the surrounding water to filter out food. But how exactly does the water flow over the coral surface, what eddies and flows develop, and what does this mean for the oxygen supply around the coral and […].

article thumbnail

Bharti Rai, Novartis VP & Head of Commercial Acceleration on What’s Ahead for 1st and 3rd party data, Insights, Analytics & Digital Data

Pharma Marketing Network

Tune in to this episode of the Pharma Marketing Podcast with Bharti Rai, Novartis VP, Chief Commercial Operations, Insight, Analytics Officer Data & Digital, for a deeper dive into what’s ahead for 1st and 3rd party data, insights, analytics & digital data. The post Bharti Rai, Novartis VP & Head of Commercial Acceleration on What’s Ahead for 1st and 3rd party data, Insights, Analytics & Digital Data appeared first on Pharma Marketing Network.

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.